Misplaced Pages

This is an old revision of this page, as edited by Hernando1620 (talk | contribs) at 23:01, 4 May 2015 (Updated corporate management information as of 2015 as well as updated description of company. Please don't revert back to the 2005 information as it is no longer relevant.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Neurocrine Biosciences" – news · newspapers · books · scholar · JSTOR (February 2008) (Learn how and when to remove this message)

Neurocrine Biosciences is a biopharmaceutical company founded in 1992 and located in San Diego, California. The company tooks its name from the original focus on therapies for neurological and endocrine diseases and disorders. The company works on discovery and development of these neurological and endocrine based diseases and disorders. The company has clinical programs that are elagolix, a gonadotropin-releasing hormone antagonist for women’s health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders.

References

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Companies in the NASDAQ Biotechnology Index
• Biotechnology companies of the United States
• Companies based in San Diego, California
• Pharmaceutical companies established in 1992
• Medical company stubs